Literature DB >> 10421241

CCR5 genotype and resistance to vertical transmission of HIV-1.

S Philpott1, H Burger, T Charbonneau, R Grimson, S H Vermund, A Visosky, S Nachman, A Kovacs, P Tropper, H Frey, B Weiser.   

Abstract

A human gene has been identified that affects susceptibility to HIV-1 infection. The gene codes for CCR5, the coreceptor for macrophage-tropic strains of HIV-1. Individuals who are homozygous for a deleted, mutant form of the gene, delta32, display a high degree of natural resistance to sexual and parenteral transmission of HIV-1. To investigate whether delta32 plays a role in vertical transmission, we determined the CCR5 genotype of 552 children born to infected mothers in the United States and correlated the genotypes with HIV-1 infection status. Of these children, 13% were white, 30% Latino, and 56% African American, reflecting the ethnic makeup of infected women in the United States. The delta32 gene frequency varied among these groups, ranging from 0.08 in whites to 0.02 in both Latinos and African Americans. Approximately 27% of the children in each ethnic group were infected. Four children were identified as delta32 homozygotes, two uninfected whites (3.77%) and two uninfected Latinos (1.68%). None of the infected children displayed the delta32 homozygous genotype. Among Latinos and whites, the number of uninfected children who carried the homozygous delta32 mutation was significantly greater than that predicted by the Hardy-Weinberg equilibrium (p < .001 for Latinos, p = .044 for whites). This association was noted in Latino and white children whose mothers were either treated or untreated with zidovudine. These data document the occurrence of the homozygous delta32 genotype among children of HIV-1-infected mothers and suggest that this mutant genotype may confer protection from mother-to-child transmission of HIV-1. They also suggest that sexual, parenteral, and vertical transmission all involve processes that use CCR5 as a coreceptor for primary HIV-1 infection. Therefore, blocking the CCR5 receptor may provide an additional strategy to prevent HIV-1 vertical transmission.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10421241     DOI: 10.1097/00126334-199907010-00002

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  15 in total

1.  Breast feeding and the risks of viral transmission.

Authors:  C A Michie; J Gilmour
Journal:  Arch Dis Child       Date:  2001-05       Impact factor: 3.791

2.  Up-regulation of CCR5 expression in the placenta is associated with human immunodeficiency virus-1 vertical transmission.

Authors:  H Behbahani; E Popek; P Garcia; J Andersson; A L Spetz; A Landay; Z Flener; B K Patterson
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

Review 3.  Molecular mechanisms of HIV-1 mother-to-child transmission and infection in neonatal target cells.

Authors:  Nafees Ahmad
Journal:  Life Sci       Date:  2010-10-01       Impact factor: 5.037

4.  Variation in the biological properties of HIV-1 R5 envelopes: implications of envelope structure, transmission and pathogenesis.

Authors:  Maria José Duenas-Decamp; Paul J Peters; Alexander Repik; Thomas Musich; Maria Paz Gonzalez-Perez; Catherine Caron; Richard Brown; Jonathan Ball; Paul R Clapham
Journal:  Future Virol       Date:  2010-07       Impact factor: 1.831

5.  CC chemokine receptor 5 genotype and susceptibility to transmission of human immunodeficiency virus type 1 in women.

Authors:  Sean Philpott; Barbara Weiser; Patrick Tarwater; Sten H Vermund; Cynthia A Kleeberger; Stephen J Gange; Kathryn Anastos; Mardge Cohen; Ruth M Greenblatt; Andrea Kovacs; Howard Minkoff; Mary A Young; Paolo Miotti; Michelle Dupuis; Chih-Hsiung Chen; Harold Burger
Journal:  J Infect Dis       Date:  2003-01-29       Impact factor: 5.226

6.  An alteration of human immunodeficiency virus gp41 leads to reduced CCR5 dependence and CD4 independence.

Authors:  Brian M Taylor; J Scott Foulke; Robin Flinko; Alonso Heredia; Anthony DeVico; Marvin Reitz
Journal:  J Virol       Date:  2008-03-19       Impact factor: 5.103

7.  Perinatal transmission of major, minor, and multiple maternal human immunodeficiency virus type 1 variants in utero and intrapartum.

Authors:  R E Dickover; E M Garratty; S Plaeger; Y J Bryson
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

8.  Analysis of 589,306 genomes identifies individuals resilient to severe Mendelian childhood diseases.

Authors:  Rong Chen; Lisong Shi; Jörg Hakenberg; Brian Naughton; Pamela Sklar; Jianguo Zhang; Hanlin Zhou; Lifeng Tian; Om Prakash; Mathieu Lemire; Patrick Sleiman; Wei-Yi Cheng; Wanting Chen; Hardik Shah; Yulan Shen; Menachem Fromer; Larsson Omberg; Matthew A Deardorff; Elaine Zackai; Jason R Bobe; Elissa Levin; Thomas J Hudson; Leif Groop; Jun Wang; Hakon Hakonarson; Anne Wojcicki; George A Diaz; Lisa Edelmann; Eric E Schadt; Stephen H Friend
Journal:  Nat Biotechnol       Date:  2016-04-11       Impact factor: 54.908

9.  Associations of chemokine receptor polymorphisms With HIV-1 mother-to-child transmission in sub-Saharan Africa: possible modulation of genetic effects by antiretrovirals.

Authors:  Kumud K Singh; Michael D Hughes; Jie Chen; Kelesitse Phiri; Christine Rousseau; Louise Kuhn; Anna Coutsoudis; J Brooks Jackson; Laura A Guay; Philippa Musoke; Francis Mmiro; Richard D Semba; Stephen A Spector
Journal:  J Acquir Immune Defic Syndr       Date:  2008-11-01       Impact factor: 3.731

10.  Host factors that influence mother-to-child transmission of HIV-1: genetics, coinfections, behavior and nutrition.

Authors:  Sascha R Ellington; Caroline C King; Athena P Kourtis
Journal:  Future Virol       Date:  2011-11-24       Impact factor: 1.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.